More News

05 Sep 2017 Retrophin Announces Cooperative Research and Development Agreement with NCATS and to Identify Potential Small Molecule Therapeutics for NGLY1 Deficiency
05 Sep 2017 $8.7 Million Awarded to Support Phase III Femoral Neck Fracture Trial by EU Horizon 2020 Program
05 Sep 2017 MorphoSys Presents Vision for Growth at its Capital Markets Day
05 Sep 2017 AMAL Therapeutics Raises €8 Million (CHF 8.8 Million) in First Closing of Series B Financing Round
05 Sep 2017 Axxam Enters Into Research Collaboration with Sanofi in the Field of Neurodegeneration
05 Sep 2017 Immunic Therapeutics Adds New Investors and Completes Series A Financing Round of Total EUR 31.7 Million
04 Sep 2017 Takeda and Noile-Immune Biotech Collaborate to Advance Next Generation CAR-T Cell Therapy Effective for Solid Tumors
01 Sep 2017 ONCURIOUS NV acquires unique portfolio of next-generation immuno-oncology assets from VIB
29 Aug 2017 Jazz Pharmaceuticals and ImmunoGen, Inc. Announce a Strategic Collaboration and Option Agreement to Develop and Commercialize Antibody-Drug Conjugate Products
29 Aug 2017 Genmab and Seattle Genetics to Co-develop Tisotumab Vedotin for Solid Tumors
29 Aug 2017 BERG Forms Research Collaboration with AstraZeneca to Identify New Therapeutic Targets to Treat Neurological Disorders such as Parkinson's Disease
29 Aug 2017 CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
29 Aug 2017 AstraZeneca and Takeda establish collaboration to develop and commercialise MEDI1341 for Parkinson’s disease
29 Aug 2017 Bristol-Myers Squibb and Daiichi Sankyo Announce Research Collaboration to Evaluate Opdivo® (nivolumab) and DS-8201 in HER2-Expressing Breast and Bladder Cancers
29 Aug 2017 Daiichi Sankyo Enters Worldwide Licensing Agreement with Boston Pharmaceuticals for a Highly Selective RET Inhibitorfor Solid Tumors
28 Aug 2017 Gilead Sciences to Acquire Kite Pharma for $11.9 Billion
26 Aug 2017 XOMA Announces Transformational License Agreements for Gevokizumab and its IL-1 Beta Intellectual Property Portfolio
26 Aug 2017 REGENXBIO to Acquire Dimension Therapeutics
25 Aug 2017 Protagonist Therapeutics Announces Closing of Janssen License and Collaboration Agreement for PTG-200 and Receipt of $50 Million Payment
25 Aug 2017 Philogen Announces Research Collaboration with Servier in the Field of DNA-Encoded Chemistry
24 Aug 2017 IDRI To Continue Development Of Inhalable TB Drug Candidate
22 Aug 2017 Topas Therapeutics signs multi-year research and option agreement with Lilly focused on immune tolerance
22 Aug 2017 Dr. Reddy's Laboratories Announces the Out-Licensing of DFD-06 to Encore Dermatology
22 Aug 2017 CRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR/Cas9 in T Cell Cancer Therapies
21 Aug 2017 Samsung Bioepis and Takeda Sign Strategic Collaboration Agreement to Co-Develop Multiple Novel Biologic Therapies

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing